Collectively, these data suggest that miR-148a-3p/ERBB3/AKT2/c-myc establishes a positive feedback loop in bladder cancer regulation, indicating that miR-148a-3p is a promising therapeutic target. This evidence concerns the gene MYC and urinary bladder carcinoma.